Interferon induction of IFITM proteins promotes infection by human coronavirus OC43

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 18, 2014, Pages 6756-6761

  Zhao, Xuesen ^a,b   Guo, Fang ^a   Liu, Fei ^a   Cuconati, Andrea ^b   Chang, Jinhong ^a   Block, Timothy M ^a,b   Guo, Ju Tao ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b BARUCH S BLUMBERG INSTITUTE   (United States)

Author keywords

Evasion of IFN response; Proviral function of IFITM; Viral pathogenesis

Indexed keywords

ALPHA INTERFERON; GAMMA INTERFERON; INTERFERON; INTERFERON INDUCED TRANSMEMBRANE PROTEIN; INTERFERON INDUCED TRANSMEMBRANE PROTEIN 2; INTERFERON INDUCED TRANSMEMBRANE PROTEIN 3; INTERFERON LAMBDA; MEMBRANE PROTEIN; OLIGOMER; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CORONAVIRUS INFECTION; ENDOCYTOSIS; GENETIC ANALYSIS; HOST CELL; HUMAN; HUMAN CELL; INTERFERON INDUCTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN STRUCTURE; REVERSE GENETICS; VIRION; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS INHIBITION;

EVASION OF IFN RESPONSE; PROVIRAL FUNCTION OF IFITM; VIRAL PATHOGENESIS;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE; CORONAVIRUS INFECTIONS; CORONAVIRUS OC43, HUMAN; CYTOKINES; HOST-PATHOGEN INTERACTIONS; HUMANS; INTERFERONS; MEMBRANE PROTEINS; MICE; MOLECULAR SEQUENCE DATA; SEQUENCE HOMOLOGY, AMINO ACID; VIRULENCE; VIRUS INTERNALIZATION;

EID: 84899804087     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1320856111     Document Type: Article

References (34)

1. W eiss SR, Navas-Martin S (2005) Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus. Microbiol Mol Biol Rev 69(4): 635-664.
2. Zaki AM, van Boheemen S , Bestebroer TM, Osterhaus AD, Fouchier RA (2012) Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 367(19):1814 -1820.
3. Dijkman R, et al. (2012) The dominance of human coronavirus OC43 and NL63 infections in infants. J Clin Virol 53(2):135-139.
4. Jean A, Quach C, Yung A, Semret M (2013) Severity and outcome associated with human coronavirus OC43 infections among children. Pediatr Infect Dis J 32(4):325-329.
5. Zielecki F, et al. (2013) Human cell tropism and innate immune system interactions of human respiratory coronavirus EMC compared to those of severe acute respiratory syndrome coronavirus. J Virol 87(9):5300-5304.
6. Brass AL, et al. (2009) The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell 139(7):1243-1254.
7. Jiang D, et al. (2010) Identification of five interferon-induced cellular proteins that inhibit west nile virus and dengue virus infections. J Virol 84(16):8332-8341.
8. Huang IC, et al. (2011) Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus. PLoS Pathog 7(1):e1001258.
9. Mudhasani R, et al. (2013) IFITM-2 and IFITM-3 but not IFITM-1 restrict Rift Valley fever virus. J Virol 87(15):8451-8464.
10. Anafu AA, Bowen CH, Chin CR, Brass AL, Holm GH (2013) Interferon-inducible transmembrane protein 3 (IFITM3) restricts reovirus cell entry. J Biol Chem 288(24): 17261-17271.
11. Diamond MS, Farzan M (2013) The broad-spectrum antiviral functions of IFIT and IFITM proteins. Nat Rev Immunol 13(1):46-57.
12. Feeley EM, et al. (2011) IFITM3 inhibits influenza A virus infection by preventing cytosolic entry. PLoS Pathog 7(10):e1002337.
13. Weidner JM, et al. (2010) Interferon-induced cell membrane proteins, IFITM3 and tetherin, inhibit vesicular stomatitis virus infection via distinct mechanisms. J Virol 84(24):126 46-12657.
14. Li K, et al. (2013) IFITM proteins restrict viral membrane hemifusion. PLoS Pathog 9(1): E1003124.
15. Amini-Bavil-Olyaee S, et al. (2013) The antiviral effector IFITM3 disrupts intracellular cholesterol homeostasis to block viral entry. Cell Host Microbe 13(4):452-464.
16. Vlasak R, Luytjes W, Leider J, Spaan W, Palese P (1988) The E3 prot ein of bovine coronavirus is a receptor-destroying enzyme with acetylesterase activity. J Virol 62(12): 4686-4690.
17. Lin TY, et al. (2013) Amphotericin B increases influenza A virus infection by preventing IFITM3-mediated restriction. Cell Rep 5(4):895-908.
18. Everitt AR, et al.; GenISIS Investigators; MOSAIC Investigators (2012) IFITM3 restricts the morbidity and mortality associated with influenza. Nature 484(7395):519-523.
19. Zuccolo J, et al. (2013) Expression of MS4A and TMEM176 genes in human B lymphocytes. Front Immunol 4:195.
20. John SP, et al. (2013) The CD225 domain of IFITM3 is required for both IFITM protein association and inhibition of influenza A virus and dengue virus replication. J Virol 87(14):7837-7852.
21. Yount JS, Karssemeijer RA, Hang HC (2012) S-palmitoylation and ubiquitination differentially regulate int erferon-induced transmembrane protein 3 (IFITM3)-mediated resistance to influenza virus. J Biol Chem 287(23):19631-19641.
22. Yount JS, et al. (2010) Palmitoylome profiling reveals S-palmitoylation-dependent antiviral activity of IFITM3. Nat Chem Biol 6(8):610-614.
23. Schoggins JW, et al. (2011) A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472(7344):481-485.
24. Jiang D, et al. (2008) Identification of three interferon-inducible cellular enzymes that inhibit the replication of hepatitis C virus. J Virol 82(4):1665-1678.
25. Metz P, Reuter A, Bender S, Bartenschlager R (2013) Interferon-stimulated genes and their role in controlling hepatitis C virus. J Hepatol 59(6):1331-1341.
26. Viswan athan K, et al. (2011) BST2/Tetherin enhances entry of human cytomegalovirus. PLoS Pathog 7(11):e1002332.
27. Seo JY, Yaneva R, Hinson ER, Cresswell P (2011) Human cytomegalovirus directly induces the antiviral protein viperin to enhance infectivity. Science 332(6033):1093-1097.
28. Hayashi J, Stoyanova R, Seeger C (2005) The transcriptome of HCV replicon expressing cell lines in the presence of alpha interferon. Virology 335(2):264-275.
29. Marcello T, et al. (2006) Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics. Gastroenterology 131(6):1887-1898.
30. Bailey CC, Kondur HR, Huang IC, Farzan M (2013) Interferon-induced transmembrane protein 3 is a type II transmembrane protein. J Biol Chem 288(45):32184-32193.
31. Jia R, et al. (2012) The N-terminal region of IFITM3 modulates its antiviral activity by regulating IFITM3 cellular localization. J Virol 86(24):13697-13707.
32. Perreira JM, Chin CR, Feeley EM, Brass AL (2013) IFITMs restrict the replication of multiple pathogenic viruses. J Mol Biol 425(24):4937-4955.
33. Wilkins C, et al. (2013) IFITM1 is a tight junction protein that inhibits hepatitis C virus entry. Hepatology 57(2):461-469.
34. Chutiwitoonchai N, et al. (2013) Characteristics of IFITM, the newly identified IFNinducible anti-HIV-1 family proteins. Microbes Infect 15(4):280-290.